Sponsored
Asia-Pacific In Vitro Diagnostics Market on Track to Reach $36.02 Billion by 2031
‘Asia-Pacific In Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach - Forecast to 2031.’
According to this latest publication from Meticulous Researchยฎ, the Asia-Pacific In Vitro Diagnostics (IVD) market is expected to reach $36.02 billion by 2031 at a CAGR of 7% from 2024 to 2031. The growth of the Asia-Pacific IVD market is attributed to the rising prevalence of chronic and infectious diseases, the growing demand for point-of-care (PoC) and rapid diagnostics, rising awareness regarding early disease diagnosis, rising healthcare expenditures, and increasing funding for research activities. However, stringent technical requirements and regulatory processes for high/moderate-complexity tests and the variance in test results observed in rapid IVD tests restrain the growth of the IVD market. The increasing inclination toward personalized medicine and advancements in genomics and proteomics are expected to create growth opportunities for the players operating in this market. However, the concerns pertaining to false positive results in immunoassays and POC are a major challenge for market growth.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5750

Key Players
The key players operating in the Asia-Pacific IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Sysmex Corporation (Japan), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Seegene Inc. (South Korea), Illumina, Inc. (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), QuidelOrtho Corporation (U.S.), and Agilent Technologies Inc. (U.S.).
Asia-Pacific IVD Market: Future Outlook
๐‡๐š๐ฏ๐ž ๐š๐ง๐ฒ ๐ช๐ฎ๐ž๐ซ๐ฒ ๐€๐’๐Š ๐„๐—๐๐„๐‘๐“ :
https://www.meticulousresearch.com/speak-to-analyst/cp_id=5750
by Offering
• Kits & Reagents
• Instruments
• Software & Services
by Technology
• Molecular Diagnostics
o Polymerase Chain Reaction (PCR)
o Hybridization
o Isothermal Nucleic Acid Amplification Technology
o DNA Sequencing & Next-generation Sequencing
o Microarrays
o Mass Spectrometry
o Other Molecular Diagnostic Technologies
• Point of Care (PoC) Diagnostics
o Lateral Flow Assays/Rapid Tests
o POC Molecular Diagnostics
o Other PoC Products
• Immunoassay/Immunochemistry
o Enzyme-linked Immunosorbent Assays (ELISA)
o Radioimmunoassays
o Western Blotting
o Enzyme-Linked Immunospot Assays
o Immunohistochemistry (IHC)
• Biochemistry/Clinical Chemistry
o Metabolic Panel
o Electrolyte Panel
o Liver Panel
o Lipid Profile
o Renal Profile
o Thyroid Function Panel
• Whole Blood Glucose Monitoring
• Microbiology
• Hematology
• Coagulation/Hemostasis
• Urinalysis
• Other IVD Technologies
by Application
• Infectious Diseases
o COVID-19 Testing
o Sexually Transmitted Diseases (STD) Testing
o Healthcare-associated Infections (HAIs)
o Hepatitis
o HIV
o Tropical Diseases
o Respiratory Infections (Excluding Influenza)
o Influenza
o Other Infectious Diseases
• Oncology
• Diabetes
• Cardiology
• Nephrology
• Autoimmune Disorders
• Other Applications
by Diagnostic Approach
• Lab Testing
• OTC/Self-testing
• Point of Care Testing
by End User
• Diagnostic Laboratories
• Hospitals & Clinics
• Home Healthcare
• Other End Users
by Country/Region
• China
• Japan
• India
• Australia
• South Korea
• Thailand
• Singapore
• Indonesia
• Rest of Asia-Pacific
Browse Here:
https://www.meticulousresearch.com/product/asia-pacific-in-vitro-diagnostics-market-5750
Key questions answered in the report:
• Which are the high-growth market segments in terms of offering, technology, application, diagnostic approach, end user, and country?
• What was the historical market for IVD testing in Asia-Pacific?
• What are the market forecasts and estimates for the period 2024–2031?
• What are the major drivers, restraints, challenges, and opportunities in the Asia-Pacific IVD market?
• Who are the major players in the Asia-Pacific IVD market?
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5750

ContactUs:
MeticulousResearchยฎ
Email- sales@meticulousresearch.com
ContactSales-+1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Asia-Pacific In Vitro Diagnostics Market on Track to Reach $36.02 Billion by 2031 ‘Asia-Pacific In Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach - Forecast to 2031.’ According to this latest publication from Meticulous Research®, the Asia-Pacific In Vitro Diagnostics (IVD) market is expected to reach $36.02 billion by 2031 at a CAGR of 7% from 2024 to 2031. The growth of the Asia-Pacific IVD market is attributed to the rising prevalence of chronic and infectious diseases, the growing demand for point-of-care (PoC) and rapid diagnostics, rising awareness regarding early disease diagnosis, rising healthcare expenditures, and increasing funding for research activities. However, stringent technical requirements and regulatory processes for high/moderate-complexity tests and the variance in test results observed in rapid IVD tests restrain the growth of the IVD market. The increasing inclination toward personalized medicine and advancements in genomics and proteomics are expected to create growth opportunities for the players operating in this market. However, the concerns pertaining to false positive results in immunoassays and POC are a major challenge for market growth. Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5750 Key Players The key players operating in the Asia-Pacific IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Sysmex Corporation (Japan), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Seegene Inc. (South Korea), Illumina, Inc. (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), QuidelOrtho Corporation (U.S.), and Agilent Technologies Inc. (U.S.). Asia-Pacific IVD Market: Future Outlook ๐‡๐š๐ฏ๐ž ๐š๐ง๐ฒ ๐ช๐ฎ๐ž๐ซ๐ฒ ๐€๐’๐Š ๐„๐—๐๐„๐‘๐“ : https://www.meticulousresearch.com/speak-to-analyst/cp_id=5750 by Offering • Kits & Reagents • Instruments • Software & Services by Technology • Molecular Diagnostics o Polymerase Chain Reaction (PCR) o Hybridization o Isothermal Nucleic Acid Amplification Technology o DNA Sequencing & Next-generation Sequencing o Microarrays o Mass Spectrometry o Other Molecular Diagnostic Technologies • Point of Care (PoC) Diagnostics o Lateral Flow Assays/Rapid Tests o POC Molecular Diagnostics o Other PoC Products • Immunoassay/Immunochemistry o Enzyme-linked Immunosorbent Assays (ELISA) o Radioimmunoassays o Western Blotting o Enzyme-Linked Immunospot Assays o Immunohistochemistry (IHC) • Biochemistry/Clinical Chemistry o Metabolic Panel o Electrolyte Panel o Liver Panel o Lipid Profile o Renal Profile o Thyroid Function Panel • Whole Blood Glucose Monitoring • Microbiology • Hematology • Coagulation/Hemostasis • Urinalysis • Other IVD Technologies by Application • Infectious Diseases o COVID-19 Testing o Sexually Transmitted Diseases (STD) Testing o Healthcare-associated Infections (HAIs) o Hepatitis o HIV o Tropical Diseases o Respiratory Infections (Excluding Influenza) o Influenza o Other Infectious Diseases • Oncology • Diabetes • Cardiology • Nephrology • Autoimmune Disorders • Other Applications by Diagnostic Approach • Lab Testing • OTC/Self-testing • Point of Care Testing by End User • Diagnostic Laboratories • Hospitals & Clinics • Home Healthcare • Other End Users by Country/Region • China • Japan • India • Australia • South Korea • Thailand • Singapore • Indonesia • Rest of Asia-Pacific Browse Here: https://www.meticulousresearch.com/product/asia-pacific-in-vitro-diagnostics-market-5750 Key questions answered in the report: • Which are the high-growth market segments in terms of offering, technology, application, diagnostic approach, end user, and country? • What was the historical market for IVD testing in Asia-Pacific? • What are the market forecasts and estimates for the period 2024–2031? • What are the major drivers, restraints, challenges, and opportunities in the Asia-Pacific IVD market? • Who are the major players in the Asia-Pacific IVD market? Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5750 ContactUs: MeticulousResearch® Email- sales@meticulousresearch.com ContactSales-+1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
0 Comments 0 Shares 2382 Views 0 Reviews
Sponsored

Instant Money Transfers - Open Free Account

Mobile Money made easy, all currencies

Sponsored